6 news items
Petros Pharmaceuticals Successfully Completes AI-Integrated Formative Human Factors Study Demonstrating Positive Interaction with Web App Designed for STENDRA(R) (avanafil) OTC Switch
PTPI
29 May 24
," "potential," "opportunity," "forecast," "should," "target," "strategy" and similar
Petros Pharmaceuticals Activates Advisory Committee to Help Guide Rx-to-OTC Switch for STENDRA
PTPI
21 May 24
," "forecast," "should," "target," "strategy" and similar expressions, whether in the negative or affirmative, that reflect
Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMe
ME
PTPI
14 May 24
," "forecast," "should," "target," "pursuit," "strategy" and similar expressions, whether in the negative
Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA(R) (avanafil) Through New Agreement with Lemonaid Health
PTPI
23 Apr 24
," "expect," "continue," "potential," "opportunity," "forecast," "should," "target
Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil)
PTPI
16 Apr 24
," "forecast," "should," "target," "pursuit," "strategy" and similar expressions, whether
5z7yltnanoa73c086o0uzh5nbshgajrfexbz380bn77cvfqfiqifkhz97
ACON
ACORQ
ADTX
2 Apr 24
RH with a Sell and raised the price target from $201 to $264.
MicroStrategy Incorporated
- Prev
- 1
- Next